The federal agency introduced Elsa last month, boasting about the AI tool's ability to increase efficiency at the FDA.

Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its “3-2-1” corporate strategy as it prepares to release interim clinical data on its lead candidate KRRO-110 in ...

A recipient of the 2025 Elite Trial Lawyers Lifetime Achievement Award, Morgan & Morgan's John Yanchunis spoke with the National Law Journal about his storied career, from bringing one of the nation’s ...

Trump administration officials have defended the mass dismissals, saying they are overdue and necessary to make the ...

Dr. Peter Marks, the former director of the FDA’s Center for Biologics Evaluation and Research, urged public health leaders ...

The U.S. Congressional Budget Office (CBO) cautioned that President Trumps proposed 2026 federal budgetfeaturing deep cuts to ...

Sarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the FDA.

Six employees died after catastrophic flooding from Helene. DA Steven Finney said no charges will be filed after the TBI ...

Heat stroke is a body’s critical call for help. You can die. Temperature rises above 104 degrees — sometimes as high as 108 ...

Trump celebrated when the Supreme Court limited nationwide blocks on his policies, but judges are finding other ways to ...

Sarepta Therapeutics’ stock has dropped precipitously as questions swirl around the safety of its gene therapies. Meanwhile, the Duchenne patient community fears losing access to Elevidys while the ...